CAMO Symposium 2025: Reaching Patients with Cancer Where They Are – Addressing Disparities in Cancer Care Delivery
Conference Venue: Fairmont The Queen Elizabeth, Montreal
Venue Address: 900 René-Lévesque Blvd W, Montreal, Quebec H3B 4A5
Directions: Google Maps Link
Book Accommodations: Discount Rates For Attendees
Event Landscape
The CAMO 2025 Symposium will explore the theme Global Oncology and Challenges in Cancer Care, with a particular focus on bidirectional learning—connecting insights from international cancer care with the challenges faced in North American settings. The session will highlight both global and local innovations, emphasizing strategies to improve access and outcomes for underserved populations.
Co-chaired by representatives from CAMO and WINC-ALINC, Dr. Scott Berry, Dr. Stephen Welch and Dr. Christine Brezden-Masley, the symposium will underscore the value of collaboration in addressing systemic disparities in cancer care both at home and around the world.
Learning Objectives
- Summarize pivotal clinical trial data from 2025 related to breast cancer management and discuss its implications for clinical practice in Canada.
- Review the latest advancements and strategies in breast cancer pathology, radiation therapy, and surgical management.
- Identify and apply evidence-based approaches to optimize the standard of care for patients with breast cancer.
Event Co-Chairs
Dr. Scott Berry
BSc, MD, MHSc, FRCPC
Dr Scott Berry – Brief Bio
Dr. Scott Berry is a medical oncologist and Chief and Medical Director of the Oncology Program at Trillium Health Partners in Mississauga. He is the interim regional vice-president for Cancer Care Ontario – Ontario Health’s Mississauga Halton Central West Regional Cancer Program and an Adjunct Professor of Oncology at Queen’s University. Dr. Berry’s clinical specialty is gastrointestinal cancer. He is actively involved in clinical research and Co-Chair of the Gastrointestinal Disease Site Group of the Cancer Cancer Ontario Program in Evidence Based Care. Dr. Berry is a medical educator who has previously served as Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology. He is one of the co-founders of OncologyEducation.com. His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues related to equitable access to cancer medications. He is a former member and ethics advisor to the pan-Canadian Oncology Drug Review Expert Review Committee and has served on the ASCO Ethics Committee.
Dr. Stephen Welch
MD, FRCPC
Associate Professor, Department of Oncology, Western University
Staff Medical Oncologist, London Regional Cancer Program, London Health Sciences Centre.
Dr. Stephen Welch joined the Department of Oncology and the Division of Medical Oncology in London, Ontario in September 2007. Currently, he is the Chair of the Division of Medical Oncology. Dr. Welch received undergraduate medicine and internal medicine credentials at the University of Manitoba and subsequently trained as a resident in medical oncology at Western University and as a clinical research fellow in oncology early phase clinical trials at the Princess Margaret Hospital in Toronto.
Dr. Christine Brezden-Masley
MD, PhD, FRCPC
Mount Sinai Hospital, Toronto, Canada
Christine Brezden-Masley, MD PhD FRCPC is a senior practicing Medical Oncologist and the Medical Director of the Cancer Program at Sinai Health System in Toronto, Canada. She is also the Director of the Marvelle Koffler Breast Centre at Sinai Health and holds the Marvelle Koffler Chair in Breast Research. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is a Professor at the Temerty Faculty of Medicine, University of Toronto and an Associate Scientist at the Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is the Past-President of the Canadian Cardio-Oncology Network (2017-2022). She also serves on the International Cardio- Oncology Society (ICOS) annual summit steering committees and co-chaired the 2022 Global Cardio-Oncology Summit in Toronto. She co-chairs the Junior Mentoring Program JuMP that fosters mentorship/sponsorship of junior medical oncology faculty across Canada and serves on the executive of WinC (Women in Cancer/All in Cancer). She is an advocate for patients and serves as a board member of ReThink Breast Cancer and MyGutFeeling and also serves on the scientific committee for the Colorectal Cancer Resource & Action Network.
Book Accommodations
As a registrant of the CAMO Symposium 2025 Conference we are pleased to offer you the CAMO Symposium 2025 discounted room rate for your stay between November 13 – 15, 2025. Reservations will be accepted while rooms remain available and are expected to sell out quickly.
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website
GOLD SPONSORS
SILVER SPONSORS
BRONZE SPONSORS
All sales are final, refunds will not be accepted.
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.
Please be advised that video and photo recording will take place during this event. By registering and attending, you consent to being photographed and filmed. These materials may be used for promotional purposes, including but not limited to social media, websites, and other communication channels. If you have any concerns or wish to discuss this further, please contact us at [email protected] before the event.
Register Now
